CRP and pulmonary embolism: The unfavorable group had higher baseline inflammatory markers (leukocytes, CRP, ferritin, and D-dimer), had received treatment with dexamethasone less often, but treatment with methylprednisolone in high dose more often, and had a higher incidence of pulmonary embolism (Table 2).